ARCHIVES

FDA Proposal On Dissemination of Off-Label Drug Information Doesn’t Go Far Enough, Cancer Groups Say

This article is from The Cancer Letter archive.

Vol. 22 No. 04 | January 26, 1996

Download PDF Visit The Full Archive

Related Articles

In Brief: Treatment Reorganization Will Give Rauscher “Lumps,” He Says; Coordinating Group Favored

August 16, 1974

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

January 31, 2003

Foreign awards Less Than 1% Of NCI Budget

June 22, 1990

In Brief: MSKCC Launches Molecular Oncology, Genomic Center

May 23, 2014

New Reagan Budget Or FY 1982 gives NCI $1.026 Billion

March 6, 1981

House, Senate Committee Increase FDA Funding, Drop User Fees

August 4, 1989